Safety Assessment of 2-Amino-3-Hydroxypyridine as Used in Cosmetics.


Journal

International journal of toxicology
ISSN: 1092-874X
Titre abrégé: Int J Toxicol
Pays: United States
ID NLM: 9708436

Informations de publication

Date de publication:
09 2020
Historique:
entrez: 25 9 2020
pubmed: 26 9 2020
medline: 3 9 2021
Statut: ppublish

Résumé

The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 2-Amino-3-Hydroxypyridine, which is reported to function as an oxidative hair dye ingredient. The Panel reviewed relevant animal and human data provided in this safety assessment, and concluded that 2-Amino-3-Hydroxypyridine is safe in the present practices of use and concentration for use in oxidative hair dye formulations.

Identifiants

pubmed: 32975151
doi: 10.1177/1091581820952376
doi:

Substances chimiques

Aminopyridines 0
Hair Dyes 0
2-amino-3-hydroxypyridine P8740PEW4B

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

91S-97S

Auteurs

Christina L Burnett (CL)

Cosmetic Ingredient Review Senior Scientific Analyst/Writer.

Wilma F Bergfeld (WF)

Expert Panel for Cosmetic Ingredient Safety Member.

Donald V Belsito (DV)

Expert Panel for Cosmetic Ingredient Safety Member.

Ronald A Hill (RA)

Expert Panel for Cosmetic Ingredient Safety Member.

Curtis D Klaassen (CD)

Expert Panel for Cosmetic Ingredient Safety Member.

Daniel C Liebler (DC)

Expert Panel for Cosmetic Ingredient Safety Member.

James G Marks (JG)

Expert Panel for Cosmetic Ingredient Safety Member.

Ronald C Shank (RC)

Expert Panel for Cosmetic Ingredient Safety Member.

Thomas J Slaga (TJ)

Expert Panel for Cosmetic Ingredient Safety Member.

Paul W Snyder (PW)

Expert Panel for Cosmetic Ingredient Safety Member.

Lillian J Gill (LJ)

Cosmetic Ingredient Review Former Director.

Bart Heldreth (B)

Cosmetic Ingredient Review Executive Director.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH